Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

NANot yet recruitingINTERVENTIONAL

Enrollment

294

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

January 30, 2026

Conditions

Atherosclerosis Cardiovascular Disease

Interventions

DIETARY_SUPPLEMENT

Icosapent-ethyl ester capsules

Icosapent-ethyl ester (4.0 g of EPA) taken twice a day (2.0 g/day x 2) for six months.

DIETARY_SUPPLEMENT

Corn oil Control

Corn oil twice a day (2.0 g/day x 2) for six months.

All Listed Sponsors

collaborator

InCor Heart Institute

OTHER

lead

University of Sao Paulo

OTHER